Announcements Trials
Browse Landscape

Status

Completed 21Unknown 11Terminated 3Active not recruiting 3Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 2Blood Specimen Collection 2osimertinib 1Trastuzumab 1Tomography, Optical Coherence 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Photochemotherapy 1Phlebotomy 1Phenotype 1Palliative Care 1Microscopy, Confocal 1Mental Status and Dementia Tests 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Interviews as Topic 1Immune Checkpoint Inhibitors 1High-Energy Shock Waves 1Health Care Economics and Organizations 1Genome 1Genetic Testing 1Focus Groups 1Consolidation Chemotherapy 1Biomarkers 1Biological Specimen Banks 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Observational × Trastuzumab × Clear all
NCT02062983 2016-05-13

Early Predictor of Herceptin Cardio Toxicity in Breast Cancer Patients

National Guard Health Affairs

Suspended
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡